Javitt Jonathan C

Average Profitability
29.02%
Insider Buys Quantity
4
Insider Buys Sum
$202,200.00
Insider Sells Quantity
10
Insider Sells Sum
$585,458.19

Insider Activity of Javitt Jonathan C

According to the SEC Form 4 filings, Javitt Jonathan C, being in a position of

  1. Chairman and Chief Scientist at NRx Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 40000 shares for $46,800, and sold 0 shares,
    over all time since 2022-06-01, has bought 440000 shares for $202,200, and sold 400000 shares for $400,000.

The largest purchase of all time was on 2023-08-22 and amounted to 200000 shares of NRx Pharmaceuticals, Inc. for $64,400.

The largest sale of all time was on 2022-12-07 and amounted to 400000 shares of NRx Pharmaceuticals, Inc. for $400,000.

Biography of Javitt Jonathan C

No biography is available at this moment.

2024-12-17PurchaseNRx Pharmaceuticals, Inc.
NRXP
Chairman and Chief Scientist
40,000
0.2543%
$1.17$46,800-10.98%
2023-08-23PurchaseNRx Pharmaceuticals, Inc.
NRXP
Chief Scientist
100,000
0.135%
$0.33$33,000+16.9%
2023-08-22PurchaseNRx Pharmaceuticals, Inc.
NRXP
Chief Scientist
200,000
0.2614%
$0.32$64,400+9.93%
2022-12-07SaleNRx Pharmaceuticals, Inc.
NRXP
director
400,000
0.4224%
$1.00$400,000-63.19%
2022-06-01PurchaseNRx Pharmaceuticals, Inc.
NRXP
Chief Scientist
100,000
0.1543%
$0.58$58,000+29.02%
2009-10-22SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
31,610
0.0447%
$0.32$10,115-31.05%
2009-10-14SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
60,000
0.1047%
$0.32$19,200-13.34%
2009-10-06SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
48,869
0.0811%
$0.34$16,371-21.21%
2009-10-05SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
87,509
0.1453%
$0.34$29,324-21.21%
2009-10-02SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
5,224
0.0089%
$0.34$1,750-18.75%
2009-10-01SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
2,800
0.0046%
$0.34$952-23.53%
2009-09-30SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
50,000
0.0859%
$0.32$15,760-12.67%
2009-09-29SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
213,988
0.3506%
$0.34$71,986-21.47%
2008-08-27SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
80,000
0.1442%
$0.25$20,000-70.37%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.